Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/3/25 16:45 | 10/1/25 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | FL | D | 4 | S | -338 | 144.72 | 0 | -2 | 46 | D | ||||||||||||||||
9/24/25 17:11 | 9/23/25 | LGND | Health | Drug | Pharmaceutical Preparations | Aryeh Jason | FL | D | 1 | S | -1,708 | 170.81 | 0 | -10 | 126 | D | ||||||||||||||||
6/24/25 20:29 | 6/23/25 | LGND | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | 5 | S.d | -577 | 104.93 | 0 | -6 | 33 | D | |||||||||||||||
3/6/25 18:55 | 3/4/25 | LGND | Health | Drug | Pharmaceutical Preparations | Espinoza Octavio | FL | O | CFO | 3 | S.d | -953 | 113.68 | 0 | -8 | 26 | D | |||||||||||||||
12/2/24 20:05 | 11/27/24 | LGND | Health | Drug | Pharmaceutical Preparations | Lamattina John L | FL | D | 1 | S.d | -298 | 123.65 | 0 | -2 | 30 | D | ||||||||||||||||
9/24/24 19:41 | 9/20/24 | LGND | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | 3 | S.dm | -5,426 | 102.09 | 0 | -53 | 68 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |